Pyxis Oncology, Inc. (PYXS)
1.76
+0.31
(+21.38%)
USD |
NASDAQ |
Jan 09, 16:00
1.79
+0.03
(+1.70%)
After-Hours: 20:00
Pyxis Oncology Research and Development Expense (Annual): 57.35M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Plus Therapeutics, Inc. | 10.58M |
| Pfizer Inc. | 10.74B |
| Ironwood Pharmaceuticals, Inc. | 109.41M |
| Akebia Therapeutics, Inc. | 31.99M |
| Xtant Medical Holdings, Inc. | 2.385M |